Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :3885
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission


This article has been cited by
1Application of analytical quality by design principles for the determination of alkyl p -toluenesulfonates impurities in Aprepitant by HPLC. Validation using total-error concept
Constantinos K. Zacharis,Elli Vastardi
Journal of Pharmaceutical and Biomedical Analysis.2018;150()152
2Influence of glutathione S transferase A1 gene polymorphism (-69C?>?T, rs3957356) on intravenous cyclophosphamide efficacy and side effects: a case-control study in Egyptian patients with lupus nephritis
Doaa H. S. Attia,Mervat Eissa,Lamees A. Samy,Rasha A. Khattab
Clinical Rheumatology.2021;40(2)753
3Doxorubicin-Induced Myocardial Fibrosis Involves the Neurokinin-1 Receptor and Direct Effects on Cardiac Fibroblasts
Scott P. Levick,David R. Soto-Pantoja,Jianli Bi,W. Gregory Hundley,Alexander Widiapradja,Edward J. Manteufel,Tancia W. Bradshaw,Giselle C. Meléndez
Heart, Lung and Circulation.2019;28(10)1598
4Pharmacological Characterization of T-2328, 2-Fluoro-4'-methoxy-3'-[[[(2S,3S)-2-phenyl-3-piperidinyl]amino]methyl]-[1,1'-biphenyl]-4-carbonitrile Dihydrochloride, as a Brain-Penetrating Antagonist of Tachykinin NK1 Receptor
Yumi Watanabe,Hidetoshi Asai,Taketoshi Ishii,Satoko Kiuchi,Masahito Okamoto,Hiroyuki Taniguchi,Masaaki Nagasaki,Akira Saito
Journal of Pharmacological Sciences.2008;106(1)121
5Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients
Michelle C Janelsins,Mohamedtaki A Tejani,Charles Kamen,Anita R Peoples,Karen M Mustian,Gary R Morrow
Expert Opinion on Pharmacotherapy.2013;14(6)757
6The 5-HT 3 Receptor Affects Rotavirus-Induced Motility
Marie Hagbom,Arash Hellysaz,Claudia Istrate,Johan Nordgren,Sumit Sharma,Felipe Meira de-Faria,Karl-Eric Magnusson,Lennart Svensson,Susana López
Journal of Virology.2021;95(15)757
7The 5-HT 3 Receptor Affects Rotavirus-Induced Motility
Jasmeet Mokha
Journal of Virology.2021;95(15)70
8Neurokinin-1 receptor (NK1R) inhibition sensitizes APL cells to anti-tumor effect of arsenic trioxide via restriction of NF-?B axis: Shedding new light on resistance to Aprepitant
Davood Bashash,Ava Safaroghli-Azar,Samaneh Bayati,Elham Razani,Atieh Pourbagheri-Sigaroodi,Arshia Gharehbaghian,Majid Momeny,Maryam Sanjadi,Mostafa Rezaie-Tavirani,Seyed H. Ghaffari
The International Journal of Biochemistry & Cell Biology.2018;103(15)105
9Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Recommendations, and New Trends
Kush Gupta,Rebecca Walton,S.P. Kataria
Cancer Treatment and Research Communications.2021;26(15)100278
10Peptide-Liganded G Protein-Coupled Receptors as Neurotherapeutics
Lee E. Eiden,Ki Ann Goosens,Kenneth A. Jacobson,Lorenzo Leggio,Limei Zhang
ACS Pharmacology & Translational Science.2020;3(2)190
11Long-Term Daily Administration of Aprepitant for the Management of Intractable Nausea and Vomiting in Children With Life-Limiting Conditions: A Case Series
Bhumik Patel,Jonathan Downie,Julie Bayliss,Andrea Stephenson,Myra Bluebond-Langner
Journal of Pain and Symptom Management.2021;62(3)e225
12Pharmacological Management of Chemotherapy-Induced Nausea and Vomiting in Children with Cancer
M.G. Cefalo,A. Ruggiero,P. Maurizi,G. Attinŕ,A. Arlotta,R. Riccardi
Journal of Chemotherapy.2009;21(6)605
13Complementary Pharmacokinetic Profiles of Netupitant and Palonosetron Support the Rationale for Their Oral Fixed Combination for the Prevention of Chemotherapy-Induced Nausea and Vomiting
James Gilmore,Alberto Bernareggi
The Journal of Clinical Pharmacology.2019;59(4)472
14Investigation of the Role of Neurokinin-1 Receptor Inhibition Using Aprepitant in the Apoptotic Cell Death through PI3K/Akt/NF-?B Signal Transduction Pathways in Colon Cancer Cells
Atefeh Ghahremanloo,Hossein Javid,Amir R. Afshari,Seyed Isaac Hashemy,Riffat Mehboob
BioMed Research International.2021;2021(4)1
15Treatment of nausea with innovative antiemetics
Yuki Fujii,Hanae Ida,Tatsushi Shimokuni,Fumihiko Haraguchi
Expert Review of Quality of Life in Cancer Care.2017;2(2)109
16Use of high-dose cisplatin with aprepitant in an outpatient setting
European Journal of Cancer Care.2012;21(4)436
  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow